Automated and Closed Cell Therapy Processing Systems Market
Market Survey on Automated and Closed Cell Therapy Processing Systems Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Automated and Closed Cell Therapy Processing Systems Market including Stem Cell Therapy and Non-Stem Cell Therapy Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Automated and Closed Cell Therapy Processing System Market Outlook
The automated and closed cell therapy processing system market is expected to expand at a 22.8% CAGR from 2023 to 2033. This market is estimated to value from US$ 1199.14 million in 2023 to US$ 9350.92 million in 2033.
Increasing Integration of Software Technologies and Sophisticated Therapy Development Procedures is also Expected to Drive Market Growth
For controlling and sustaining the cell therapy process, automated and closed cell therapy processing systems are used. The system includes manufacturing software and hardware, which aids in the entire research and development process. The technology is a gift to researchers because it assists them in clinical studies through commercial approval. This can aid in the development and avoidance of manual manufacturing delays. Several scale levels of standardisation can be accomplished for diverse production processes.
Researchers believe automated and closed cell therapy processing systems to be simple to use and dependable, as they aid in converting cell therapy from discovery to commercialization.
The increasing number of investments in the market for automated and closed cell therapy processing systems is the key driver of market expansion in the next years. Furthermore, the growing number of cell therapies provides the market with profitable potential. Cell treatment processing is a critical activity that necessitates extreme precision while treating the cells.
The usage of physical labor has been determined to be inefficient because it increases the risk of the process. Also, manual processing increases the possibility of contamination. As a result, the combination of advanced medicines and automated systems is quickly rising.
The adoption of automated systems has aided in the centralization of cell therapy processes, which has benefited manufacturers in a variety of ways.
|
Report Attribute |
Details |
|
Automated and Closed Cell Therapy Processing System Market Value (2023) |
US$ 1199.14 million |
|
Automated and Closed Cell Therapy Processing System Market Anticipated Value (2033) |
US$ 9350.92 million |
|
Automated and Closed Cell Therapy Processing System Market Growth Rate (2023 to 2033) |
22.8% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2018 to 2022 Automated and Closed Cell Therapy Processing System Market Outlook in Comparison to 2023 to 2033 Growth Forecast
The automated and closed cell therapy processing system market accounted for US$ 976.50 million in 2022, expanding at a 22.4% CAGR from 2018 to 2022.
Cell therapy technologies are critical in medicine and the cell therapy sector, which has arisen as a crucial factor in medical practice. Furthermore, various cell treatment approaches share functions such as medication delivery, gene therapy, cancer vaccinations, tissue engineering, and regenerative medicine. The distribution of cell therapy products can range from injections to surgical implantation using specialized equipment.
The increasing popularity of regenerative medicines and cell therapies is one of the important factors driving the market growth. The multiple advantages afforded by automation technologies for the development of these therapies are further driving market expansion. Furthermore, the increasing mix of software technologies and complex therapy development techniques is bolstering the market growth.
|
Historical CAGR (2018 to 2022) |
Forecast CAGR (2023 to 2033) |
|
22.4% |
22.8% |
As per the FMI analysts, a valuation of US$ 9350.92 million by 2033 end is estimated for the market.
| 2016 | US$ 284.76 million |
| 2021 | US$ 795.20 million |
| 2022 | US$ 976.50 million |
| 2023 | US$ 1199.14 million |
| 2033 | US$ 9350.92 million |
Comparative Analysis of Adjacent Markets
Automated and Closed Cell Therapy Processing System Market:
|
Differentiating Aspects |
Automated and Closed Cell Therapy Processing System Market |
|
Anticipated CAGR (2023 to 2033) |
22.8% |
|
Market Valuation (2023) |
US$ 1199.14 million |
|
Growth Factors |
The market is being boosted by the variety of benefits provided by automation technologies, as well as an increasing number of technological developments linked with cell therapy processing. |
|
Future Opportunities |
Rising investments by bio manufacturers in the development of cellular treatment products via a series of funding rounds are expected to provide attractive prospects to enter the industry. |
|
Market Trends |
Clinical trials for innovative medicines are expected to skyrocket in the coming years. As a result of this expansion, there is a great demand for innovative and automated technologies that produce high throughput and yield. |
Cell Therapy Market:
|
Differentiating Aspects |
Cell Therapy Market |
|
Anticipated CAGR (2023 to 2033) |
14.17% |
|
Market Valuation (2023) |
US$ 24.66 million |
|
Growth Factors |
The increase in financing for cell therapy clinical trials, as well as the development of relevant guidelines for cell therapy manufacturing, are some of the primary drivers impacting the market growth. |
|
Future Opportunities |
The cell treatment market is constantly expanding to encompass new cell types, creating a huge opportunity for companies to increase their market positions. |
|
Market Trends |
Some of the primary causes driving expansion are physicians' increased propensity toward the therapeutic use of allogeneic therapies and rising awareness regarding the use of cord cells and tissues across numerous therapeutic sectors. |
Lung Cancer Therapeutics Market:
|
Differentiating Aspects |
Lung Cancer Therapeutics Market |
|
Anticipated CAGR (2023 to 2033) |
13.2% |
|
Market Valuation (2023) |
US$ 34067.30 million |
|
Growth Factors |
Increasing demand for tailored therapeutics might drive market expansion. |
|
Future Opportunities |
The increasing prevalence of lung cancer and other chronic diseases has fueled the usage of lung cancer therapies in both emerging and developed countries. |
|
Market Trends |
Increased research and development in the field of lung cancer therapies are also promoting their rise. |
Find your sweet spots for generating winning opportunities in this market.
Increasing Interest in Regenerative Medicine
Regenerative medicine is a branch of medicine that involves the replacement of damaged tissues or organs. Regenerative medicine is concerned with replacing and rebuilding tissue or organ damage caused by a specific disease or event.
The growing importance of stem cells in regenerative medicine results in increasing demand for regenerative medicine from the healthcare industry. This factor remains a significant factor driving the creation of automated and closed-cell therapy processing systems.
Cancer and other chronic diseases that require long-term therapy have increased the popularity of regenerative medicine. Stem cell uses are part of regenerative medicine. Stem cells can be divided indefinitely and are employed as a first-line source for regenerative therapy.
Regenerative medicine is a branch of medicine that uses various methods to repair, regrow, or replace diseased or damaged cells, organs, or tissues. Furthermore, regenerative medicine encompasses the synthesis and application of therapeutic stem cells, tissue development, and the creation of artificial organs. Due to their high accuracy and effectiveness, regenerative medicines and cell therapies are expected to see a surge in demand, driving the market growth.
Chronic Disease Prevalence is Increasing
Chronic disease refers to a category of diseases that include cardiovascular disease, cancer, and diabetes, among others. The global population is experiencing an increase in the prevalence of chronic diseases. It is primarily linked to sedentary behavior, an unhealthy diet, and cigarette use.
Chronic disease, according to the USA Centers for Disease Control and Prevention (CDC), is a condition that lasts longer than a year. This disease requires prompt medical attention. It limits everyday activities also.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Scarcity of Trained Professionals
As cell therapies become popular, the market for automated processing systems needs experienced personnel to perform these therapies and operate automated systems. The shortage of skilled specialists, on the other hand, is expected to stymie the expansion of the automated and closed cell therapy processing system market over the forecast period.
The use of technologically advanced and extremely intricate flow cytometers and spectrophotometers to generate a large number of data outputs that require knowledge to comprehend and assess might impede the market growth.
Raw Material Scarcity
The complete cell therapy manufacturing process is made up of several phases, each of which requires a starting material. The global need for automated and closed-cell therapy processing systems has resulted in a scarcity of raw materials required for good medical practice (GMP).
The market is experiencing a bottleneck in the supply of plasmids and viral vectors, which are proven GMP-based raw materials necessary in the cell therapy process.
The difficulties in procuring starting materials such as bone marrow, blood, and apheresis provide a hindrance to the market's expansion. As a result, the global automated and closed-cell therapy processing system market is constrained by a scarcity of raw materials.
Increasing Pharmaceutical Research and Development Activities
Governments and big pharmaceutical corporations are investing in research and development to accelerate the discovery of new therapies for a variety of health ailments. Increasing research and development investment in cell therapy research might promote market expansion by facilitating the discovery of novel automated and closed-cell therapies.
Increased research and development efforts in the pharmaceutical sector are expected to provide significant income for the market.
A Glimpse of Country-wise Insights
The United States of America Automated and Closed Cell Therapy Processing System Market Analysis
The United States of America with a CAGR of 20.7% from 2015 to 2021 is the prominent market for automated and closed cell therapy. The market for automated and closed cell therapy processing systems in the United States of America is expected to cross US$ 2.2 million by the end of 2032 with an absolute dollar opportunity of US$ 1.9 Million.
The United Kingdom Automated and Closed Cell Therapy Processing System Market Analysis
The market in the United Kingdom is expected to reach a valuation of US$ 312 million by 2032. Growing at a CAGR of 21.2%, the market in the country is projected to cross an absolute dollar opportunity of US$ 155.3 million from 2022 to 2032.
Japan Automated and Closed Cell Therapy Processing Systems Market Analysis
In Japan, the market is projected to register a CAGR of 24.1% during the forecast period. With an absolute dollar opportunity of US$ 262 million from 2022 to 2032, the market in the country is expected to reach US$ 296 million by 2032.
South Korea Automated and Closed Cell Therapy Processing Systems Market Analysis
The market in South Korea is expected to reach US$ 193 million by 2032. With a CAGR of 26.1% during the forecast period, the market is expected to register an absolute dollar opportunity of US$ 173 Million.
Category-Wise Insights
The Separation Segment is Expected to Increase Profitably
The separation workflow category is predicted to expand significantly in the automated and closed-cell therapy processing system market. Separation is an important component of the closed-cell therapy processing system.
Separation of cell components is required for doing the research in a timely manner. The cell separation revealed minute data about genetic modification, molecular analysis, hybridoma creation, and so on. As a result, cell separation is critical for future research and development in research and academic contexts.
Why Non-stem Cell Therapy is Gaining the Utmost Traction when Compared with Other Types?
The market for the Non-Stem Cell Therapy type expanded at a CAGR of 17.2% from 2015 to 2021. The success of CAR-T therapies has shifted investment to non-stem cell therapy development, resulting in increased revenue for the industry.
Companies in the market are hugely collaborating and forming partnerships in order to create new regenerative therapies for the treatment of chronic diseases. Such research efforts are primarily focused on non-stem cell uses, which is fueling the non-stem cell treatment segment's expansion.
The enormous therapeutic potential of cell and tissue-based engineering is predicted to allow the segment to increase at a notable rate during the forecast period.
Competitive Landscape
Some of the recent developments of automated and closed cell therapy processing System Market providers are as follows:
- In February 2021, Cytiva and Brooks Life Sciences agreed to expand the automated cold chain's capabilities.
- In October 2021, Terumo worked with BioCentriq Laboratories, a cell, and gene therapy trial manufacturing facility. This collaboration is expected to bring together the companies' respective automation and CDMO knowledge, products, and talents.
- In August 2020, Lonza and IsoPlexis, a life science technology company, collaborated. The goal of this collaboration was to advance cell therapy manufacturing.
Key Companies Operating in the Market
- Miltenyi Bio tec
- Lonza
- Fresenius Kabi
- Cytiva
- Bio Spherix
- Terumo
- Cellares
- Sartorius
Scope of Report
|
Attribute |
Details |
|
Market Size Value In 2023 |
US$ 1199.14 million |
|
Market Size Value in End of Forecast (2033) |
US$ 9350.92 million |
|
Market Analysis |
US$ million for Value |
|
Key Region Covered |
|
|
Key Segments |
|
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Automated and Closed Cell Therapy Processing System Market Key Segmentation
By Type:
- Stem Cell Therapy
- Non-Stem Cell Therapy
By Workflow:
- Separation
- Expansion
- Apheresis
- Fill-Finish
- Cryopreservation
By Scale:
- Pre-commercial/Research and Development Scale
- Commercial Scale
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
What is the Present Automated and Closed Cell Therapy Processing Systems Market Size?
The automated and closed cell therapy processing systems market size will reach US$ 1199.14 million in 2023.
What Size is the Automated and Closed Cell Therapy Processing Systems Market Expected to Reach by 2033?
The automated and closed cell therapy processing systems market is set to surge at a robust 22.8% CAGR, reaching a noteworthy valuation of US$ 9350.92 million by 2033.
What was the Automated and Closed Cell Therapy Processing Systems Market's Past Record like?
The automated and closed cell therapy processing systems market demonstrated a 22.4% CAGR from 2018 to 2022, recording a valuation of US$ 976.50 million in 2022
What Key Opportunities does the Automated and Closed Cell Therapy Processing Systems Market Present for Stakeholders?
The automated and closed cell therapy processing systems market beckons stakeholders with opportunities in innovative medical technologies.
Which Segment Accounted for the Leading Automated and Closed Cell Therapy Processing Systems Market Size By Type?
The non-stem cell therapy type demonstrated significant expansion, registering a robust CAGR of 17.2% between 2015 and 2021.
Table of Content
1. Executive Summary | Automated and Closed Cell Therapy Processing System Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Workflow 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Workflow, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Workflow, 2023 to 2033 5.3.1. Cryopreservation 5.3.2. Fill-finish 5.3.3. Separation 5.3.4. Expansion 5.3.5. Apheresis 5.3.6. Others 5.4. Y-o-Y Growth Trend Analysis By Workflow, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Workflow, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033 6.3.1. Stem Cell Therapy 6.3.2. Non-stem Cell Therapy 6.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Scale 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Scale, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Scale, 2023 to 2033 7.3.1. Commercial Scale 7.3.2. R&D Scale 7.4. Y-o-Y Growth Trend Analysis By Scale, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Scale, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Workflow 9.2.3. By Type 9.2.4. By Scale 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Workflow 9.3.3. By Type 9.3.4. By Scale 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Workflow 10.2.3. By Type 10.2.4. By Scale 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Workflow 10.3.3. By Type 10.3.4. By Scale 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Workflow 11.2.3. By Type 11.2.4. By Scale 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Workflow 11.3.3. By Type 11.3.4. By Scale 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Workflow 12.2.3. By Type 12.2.4. By Scale 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Workflow 12.3.3. By Type 12.3.4. By Scale 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Workflow 13.2.3. By Type 13.2.4. By Scale 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Workflow 13.3.3. By Type 13.3.4. By Scale 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Workflow 14.2.3. By Type 14.2.4. By Scale 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Workflow 14.3.3. By Type 14.3.4. By Scale 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Workflow 15.2.3. By Type 15.2.4. By Scale 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Workflow 15.3.3. By Type 15.3.4. By Scale 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Workflow 16.1.2.2. By Type 16.1.2.3. By Scale 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Workflow 16.2.2.2. By Type 16.2.2.3. By Scale 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Workflow 16.3.2.2. By Type 16.3.2.3. By Scale 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Workflow 16.4.2.2. By Type 16.4.2.3. By Scale 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Workflow 16.5.2.2. By Type 16.5.2.3. By Scale 16.6. United kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Workflow 16.6.2.2. By Type 16.6.2.3. By Scale 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Workflow 16.7.2.2. By Type 16.7.2.3. By Scale 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Workflow 16.8.2.2. By Type 16.8.2.3. By Scale 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Workflow 16.9.2.2. By Type 16.9.2.3. By Scale 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Workflow 16.10.2.2. By Type 16.10.2.3. By Scale 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Workflow 16.11.2.2. By Type 16.11.2.3. By Scale 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Workflow 16.12.2.2. By Type 16.12.2.3. By Scale 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Workflow 16.13.2.2. By Type 16.13.2.3. By Scale 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Workflow 16.14.2.2. By Type 16.14.2.3. By Scale 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Workflow 16.15.2.2. By Type 16.15.2.3. By Scale 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Workflow 16.16.2.2. By Type 16.16.2.3. By Scale 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Workflow 16.17.2.2. By Type 16.17.2.3. By Scale 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Workflow 16.18.2.2. By Type 16.18.2.3. By Scale 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Workflow 16.19.2.2. By Type 16.19.2.3. By Scale 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Workflow 16.20.2.2. By Type 16.20.2.3. By Scale 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Workflow 16.21.2.2. By Type 16.21.2.3. By Scale 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Workflow 17.3.3. By Type 17.3.4. By Scale 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Lonza 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. BioSpherix 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Cellares 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Sortorius 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Cytiva 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. ThermoGenesis Holdings Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Thermo Fisher Scientific Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. MiltenyiBiotec 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Fresenius Kabi 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Pfizer 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Scale, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Scale, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Scale, 2018 to 2033 Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Europe Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 15: Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by Scale, 2018 to 2033 Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: South Asia Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 19: South Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 20: South Asia Market Value (US$ Million) Forecast by Scale, 2018 to 2033 Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: East Asia Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 23: East Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 24: East Asia Market Value (US$ Million) Forecast by Scale, 2018 to 2033 Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: Oceania Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 27: Oceania Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 28: Oceania Market Value (US$ Million) Forecast by Scale, 2018 to 2033 Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: MEA Market Value (US$ Million) Forecast by Workflow, 2018 to 2033 Table 31: MEA Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 32: MEA Market Value (US$ Million) Forecast by Scale, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Type, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Scale, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 17: Global Market Attractiveness by Workflow, 2023 to 2033 Figure 18: Global Market Attractiveness by Type, 2023 to 2033 Figure 19: Global Market Attractiveness by Scale, 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Type, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by Scale, 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 37: North America Market Attractiveness by Workflow, 2023 to 2033 Figure 38: North America Market Attractiveness by Type, 2023 to 2033 Figure 39: North America Market Attractiveness by Scale, 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Type, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by Scale, 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 57: Latin America Market Attractiveness by Workflow, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Type, 2023 to 2033 Figure 59: Latin America Market Attractiveness by Scale, 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Europe Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 62: Europe Market Value (US$ Million) by Type, 2023 to 2033 Figure 63: Europe Market Value (US$ Million) by Scale, 2023 to 2033 Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Europe Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 69: Europe Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 71: Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 72: Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 75: Europe Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 76: Europe Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 77: Europe Market Attractiveness by Workflow, 2023 to 2033 Figure 78: Europe Market Attractiveness by Type, 2023 to 2033 Figure 79: Europe Market Attractiveness by Scale, 2023 to 2033 Figure 80: Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: South Asia Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 82: South Asia Market Value (US$ Million) by Type, 2023 to 2033 Figure 83: South Asia Market Value (US$ Million) by Scale, 2023 to 2033 Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: South Asia Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 89: South Asia Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 91: South Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 92: South Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 94: South Asia Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 95: South Asia Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 96: South Asia Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 97: South Asia Market Attractiveness by Workflow, 2023 to 2033 Figure 98: South Asia Market Attractiveness by Type, 2023 to 2033 Figure 99: South Asia Market Attractiveness by Scale, 2023 to 2033 Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 101: East Asia Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 102: East Asia Market Value (US$ Million) by Type, 2023 to 2033 Figure 103: East Asia Market Value (US$ Million) by Scale, 2023 to 2033 Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: East Asia Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 109: East Asia Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 111: East Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 112: East Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 114: East Asia Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 115: East Asia Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 117: East Asia Market Attractiveness by Workflow, 2023 to 2033 Figure 118: East Asia Market Attractiveness by Type, 2023 to 2033 Figure 119: East Asia Market Attractiveness by Scale, 2023 to 2033 Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 121: Oceania Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 122: Oceania Market Value (US$ Million) by Type, 2023 to 2033 Figure 123: Oceania Market Value (US$ Million) by Scale, 2023 to 2033 Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: Oceania Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 129: Oceania Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 131: Oceania Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 132: Oceania Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 134: Oceania Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 135: Oceania Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 136: Oceania Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 137: Oceania Market Attractiveness by Workflow, 2023 to 2033 Figure 138: Oceania Market Attractiveness by Type, 2023 to 2033 Figure 139: Oceania Market Attractiveness by Scale, 2023 to 2033 Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 141: MEA Market Value (US$ Million) by Workflow, 2023 to 2033 Figure 142: MEA Market Value (US$ Million) by Type, 2023 to 2033 Figure 143: MEA Market Value (US$ Million) by Scale, 2023 to 2033 Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: MEA Market Value (US$ Million) Analysis by Workflow, 2018 to 2033 Figure 149: MEA Market Value Share (%) and BPS Analysis by Workflow, 2023 to 2033 Figure 150: MEA Market Y-o-Y Growth (%) Projections by Workflow, 2023 to 2033 Figure 151: MEA Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 152: MEA Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 153: MEA Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 154: MEA Market Value (US$ Million) Analysis by Scale, 2018 to 2033 Figure 155: MEA Market Value Share (%) and BPS Analysis by Scale, 2023 to 2033 Figure 156: MEA Market Y-o-Y Growth (%) Projections by Scale, 2023 to 2033 Figure 157: MEA Market Attractiveness by Workflow, 2023 to 2033 Figure 158: MEA Market Attractiveness by Type, 2023 to 2033 Figure 159: MEA Market Attractiveness by Scale, 2023 to 2033 Figure 160: MEA Market Attractiveness by Country, 2023 to 2033
Explore Healthcare Insights
View Reports
